Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter Becker

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
The Journal of Biological Chemistry|December 4, 2010
Splice variants of the dual specificity tyrosine phosphorylation-regulated kinase 4 (DYRK4) differ in their subcellular localization and catalytic activityChrisovalantis Papadopoulos, Krisztina Arato, Eva Lilienthal, et al.
ACS Chemical Neuroscience|November 2, 2021
Discovery of Hydroxybenzothiazole Urea Compounds as Multitargeted Agents Suppressing Major Cytotoxic Mechanisms in Neurodegenerative DiseasesYoussef Aboushady, Moustafa Gabr, Ahmed K ElHady, et al.
European Journal of Medicinal Chemistry|October 28, 2021
Discovery of novel 6-hydroxybenzothiazole urea derivatives as dual Dyrk1A/α-synuclein aggregation inhibitors with neuroprotective effectsYasmeen T AlNajjar, Moustafa Gabr, Ahmed K ElHady, et al.
International Journal of Molecular Sciences|May 14, 2025
A Single-Domain VNAR Nanobody Binds with High-Affinity and Selectivity to the Heparin Pentasaccharide FondaparinuxMartha Gschwandtner, Rupert Derler, Elisa Talker, et al.
Nucleic Acids Research|July 17, 2025
Sequence, structure, and affinity of miR-34a binding sites determine repression efficacyLara Sweetapple, David M Kosek, Elnaz Banijamali, et al.
Journal of Medicinal Chemistry|March 3, 2015
10-iodo-11H-indolo[3,2-c]quinoline-6-carboxylic acids are selective inhibitors of DYRK1AHannes Falke, Apirat Chaikuad, Anja Becker, et al.
RNA (New York, N.Y.)|January 9, 2023
RNA:RNA interaction in ternary complexes resolved by chemical probingElnaz Banijamali, Lorenzo Baronti, Walter Becker, et al.
The Journal of Biological Chemistry|September 6, 2021
Structural and DNA-binding properties of the cytoplasmic domain of Vibrio cholerae transcription factor ToxRNina Gubensäk, Evelyne Schrank, Christoph Hartlmüller, et al.
Journal of Medicinal Chemistry|September 30, 2024
Discovery and Functional Characterization of a Potent, Selective, and Metabolically Stable PROTAC of the Protein Kinases DYRK1A and DYRK1BGerrit Wilms, Kevin Schofield, Shayna Maddern, et al.
Cancers|August 27, 2021
The Unfolded Protein Response Is a Major Driver of LCN2 Expression in BCR-ABL- and JAK2V617F-Positive MPNStefan Tillmann, Kathrin Olschok, Sarah K Schröder, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
The Journal of Biological Chemistry|December 4, 2010
Splice variants of the dual specificity tyrosine phosphorylation-regulated kinase 4 (DYRK4) differ in their subcellular localization and catalytic activityChrisovalantis Papadopoulos, Krisztina Arato, Eva Lilienthal, et al.
ACS Chemical Neuroscience|November 2, 2021
Discovery of Hydroxybenzothiazole Urea Compounds as Multitargeted Agents Suppressing Major Cytotoxic Mechanisms in Neurodegenerative DiseasesYoussef Aboushady, Moustafa Gabr, Ahmed K ElHady, et al.
European Journal of Medicinal Chemistry|October 28, 2021
Discovery of novel 6-hydroxybenzothiazole urea derivatives as dual Dyrk1A/α-synuclein aggregation inhibitors with neuroprotective effectsYasmeen T AlNajjar, Moustafa Gabr, Ahmed K ElHady, et al.
International Journal of Molecular Sciences|May 14, 2025
A Single-Domain VNAR Nanobody Binds with High-Affinity and Selectivity to the Heparin Pentasaccharide FondaparinuxMartha Gschwandtner, Rupert Derler, Elisa Talker, et al.
Nucleic Acids Research|July 17, 2025
Sequence, structure, and affinity of miR-34a binding sites determine repression efficacyLara Sweetapple, David M Kosek, Elnaz Banijamali, et al.
Journal of Medicinal Chemistry|March 3, 2015
10-iodo-11H-indolo[3,2-c]quinoline-6-carboxylic acids are selective inhibitors of DYRK1AHannes Falke, Apirat Chaikuad, Anja Becker, et al.
RNA (New York, N.Y.)|January 9, 2023
RNA:RNA interaction in ternary complexes resolved by chemical probingElnaz Banijamali, Lorenzo Baronti, Walter Becker, et al.
The Journal of Biological Chemistry|September 6, 2021
Structural and DNA-binding properties of the cytoplasmic domain of Vibrio cholerae transcription factor ToxRNina Gubensäk, Evelyne Schrank, Christoph Hartlmüller, et al.
Journal of Medicinal Chemistry|September 30, 2024
Discovery and Functional Characterization of a Potent, Selective, and Metabolically Stable PROTAC of the Protein Kinases DYRK1A and DYRK1BGerrit Wilms, Kevin Schofield, Shayna Maddern, et al.
Cancers|August 27, 2021
The Unfolded Protein Response Is a Major Driver of LCN2 Expression in BCR-ABL- and JAK2V617F-Positive MPNStefan Tillmann, Kathrin Olschok, Sarah K Schröder, et al.
Pageof 7